cbdMD, Inc.
For the period ended Mar 29, 2024. Filed Feb 14, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
Mar 29, 2024 · Filed Feb 14, 2024
YCBD$0.42+7.2%Stored close · as of Nov 6, 2026
Contents
Proxy Summary
| WHEN | ITEMS OF BUSINESS |
|---|---|
| Friday, March 29, 2024 at 1:00 p.m. EST | ➢ the election of four directors; |
| WHERE | ➢ the ratification of the appointment of Cherry Bekaert LLP as our independent registered public accounting firm; |
| Virtual - https://agm.issuerdirect.com/ycbd | |
| ➢ a non-binding advisory vote on the frequency of an advisory vote on executive compensation; | |
| ➢ a non-binding advisory vote on executive compensation; | |
| RECORD DATE | |
| January 30, 2024 | ➢ the approval and adoption of an amendment to the Company’s Certificate of Designation for the Series A Preferred Stock to provide that each share of Series A Preferred Stock will be automatically converted into six shares of common stock; and |
| ➢ the approval of the issuance of shares of our common stock, representing more than 19.9% of our common stock outstanding as of January 30, 2024 upon the conversion of certain convertible notes issued by the Company pursuant to a Securities Purchase Agreement dated as of January 30, 2024, by and between the Company and certain institutional investors, in connection with a private placement in accordance with NYSE American Rule 713(a)(ii); | |
| ➢ a proposal to adjourn the annual meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the annual meeting, there are not sufficient votes to approve any proposal; and | |
| ➢ any other business as my properly come before the meeting. | |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.